Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) entered into a convertible promissory note (the “Note”) with Robert Noel Robinson (the “Lender”) in an aggregate principal amount of $600,000. Adamis Pharmaceuticals Corp (NASDAQ:ADMP) shares after opening at $6.32 moved to $6.32 on last trade day and at the end of the day closed at $6.06. Company price to cash ratio as 13.50. Adamis Pharmaceuticals Corp (NASDAQ:ADMP) showed a negative weekly performance of -4.57%.
Raleigh diagnostics company LipoScience, Inc. (NASDAQ:LPDX) terminated its relationship with Health Diagnostics Laboratory, Inc, one of its laboratory customers, after HDL began offering its own version of roughly the same test LipoScience manufactures. LipoScience Inc. (NASDAQ:LPDX) shares advanced 2.92% in last trading session and ended the day on $3.17. LPDX return on equity ratio is recorded as -33.80% and its return on assets is -14.40%. LipoScience Inc. (NASDAQ:LPDX) yearly performance is -66.70%.
American Bio Medica Corporation (OTCMKTS:ABMC) on 28 march announced financial results for the fourth quarter and year ended December 31, 2013. American Bio Medica Corporation (OTCMKTS:ABMC) shares moved down -4.76% in last trading session and was closed at $0.110, while trading in range of $0.10 – $0.12. American Bio Medica Corporation (OTCMKTS:ABMC) year to date (YTD) performance is -15.38%.
Myrexis Inc. (OTCMKTS:MYRX) weekly performance is 13.75%. On last trading day company shares ended up $0.182. Myrexis Inc. (OTCMKTS:MYRX) distance from 50-day simple moving average (SMA50) is 9.51%. Analysts mean target price for the company is $5.00.